Fixed-Dose Cannabinoid–Mushroom Combination for Immune Balance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current chemotherapeutic agents for cancer treatment often damage healthy cells and suppress immune responses, diminishing their anti-tumor effects, while cannabinoids may negatively affect immune stimulation and anti-inflammatory processes required for certain conditions.
Innovation Solution
A synergistic combination of cannabis-derived compounds, such as cannabinoids, and medicinal mushrooms, specifically targeting CB1 or CBD receptors and pattern-recognition receptors (PRR), to provide anti-inflammatory and immune-stimulatory effects without suppressing immune-mediated processes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If chemotherapeutic agents are used to treat cancer, then tumor destruction and cancer progress arrest are improved, but damage to healthy cells and tissues increases and immune suppression occurs
Solution Approach 1:
The patent combines cannabinoids and medicinal mushrooms into a composite therapeutic formulation. This composite approach leverages the anti-tumor properties of cannabinoids while the medicinal mushrooms provide immune-stimulating effects that counteract the immune suppression caused by chemotherapeutic agents, thereby protecting healthy cells and enhancing overall anti-tumor efficacy
Solution Approach 2:
Medicinal mushrooms act as an intermediary substance that mediates between the harmful immune-suppressing effect of chemotherapeutic agents and the need for immune function. The mushrooms stimulate immune responses and reduce inflammation, effectively counterbalancing the negative immune effects of chemotherapy while preserving its anti-tumor benefits
2Object-affected harmful factors
If cannabinoids are used for their anti-inflammatory effect, then inflammation is reduced, but immune stimulation is suppressed
Solution Approach 1:
The medicinal mushrooms provide a counterbalancing effect to the immune-suppressing action of cannabinoids. While cannabinoids reduce inflammation through anti-inflammatory mechanisms, the mushrooms simultaneously stimulate immune responses, creating a counterweight that prevents excessive immune suppression while maintaining beneficial anti-inflammatory effects
3Reliability
If a fixed dose combination of cannabinoids and medicinal mushrooms is used, then synergistic anti-inflammatory and immune-stimulatory effects are achieved, but treatment complexity increases
Solution Approach 1:
The patent merges cannabinoids and medicinal mushrooms into a single fixed-dose combination formulation. This merging integrates multiple therapeutic mechanisms (anti-inflammatory, immune-stimulatory, anti-tumor) into one unified treatment, simplifying administration while achieving synergistic effects that enhance therapeutic efficacy beyond what either substance could provide alone
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination offers a safer and more effective treatment for cancer and immune-mediated inflammatory diseases by balancing anti-inflammatory and immune-stimulatory properties, enhancing therapeutic outcomes without compromising immune function.
Implementation Method 1
a cannabis-derived compound agonistic to CB1 or CBD receptors
Implementation Method 2
a medicinal mushroom agonistic to pattern-recognition receptors (PRR)
Data Source
AI summary
A composition useful for treating immune-mediated inflammatory diseases or cancer in mammalian subjects is disclosed. The composition comprises a synergistic combination of a cannabis derived compound, and a medicinal mushroom.